New pain relief hope for elderly frozen shoulder patients

NCT ID NCT07088562

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 29 times

Summary

This study tested a treatment called pulsed radiofrequency on the suprascapular nerve to relieve pain and improve shoulder function in 32 elderly patients with frozen shoulder (adhesive capsulitis). The treatment uses low-temperature energy to block pain signals without damaging the nerve. Researchers measured pain levels and disability scores to see if it helps this hard-to-treat condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHESIVE CAPSULITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • İKanuni Sultan Süleyman Training and Research Hospital

    Küçükçekmece, Istanbul, (507) 277-4773, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pulsed radiofrequency applied to the suprascapular nerve

What this could lead to

If effective, this could provide a safer, non-destructive pain relief option for elderly patients with frozen shoulder, reducing the need for surgery or strong painkillers.

What could go wrong

This is a small, completed study with only 32 participants and no control group, so results may not apply to everyone. The treatment is for symptom relief, not a cure.

Conditions

The condition(s) this trial relates to.

bursitis frozen shoulder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.